Emily L. Larkin

1.1k citations
13 papers · 922 indexed · 1 hit paper · h-index 11
Topics
Antifungal resistance and susceptibility (7 papers)Fungal Infections and Studies (6 papers)Essential Oils and Antimicrobial Activity (2 papers)
Partner nations
United States

In The Last Decade

Emily L. Larkin

13 papers receiving 900 citations

Hit Papers

The Emerging Pathogen Candida auris: Growth Phenotype, Vi...20172026202020232017100200300

Peers

Emily L. Larkin
Comparison fields: 5 of 71
  • Infectious Diseases 785
  • Epidemiology 611
  • Molecular Biology 94
  • Food Science 89
  • Organic Chemistry 85
Replace Afsane Vaezi with:
Afsane Vaezi Iran
Anna Prigitano Italy
Alba Ruiz‐Gaitán Spain
Farnaz Daneshnia Netherlands
Elaine Cristina Francisco Brazil
Seyed Jamal Hashemi Iran
Indira Berrío Colombia
Milena Kordalewska United States
Belinda Calvo Venezuela
Leticia Bernal‐Martínez Spain
Emily L. Larkin relative to Afsane Vaezi Iran Afsane Vaezi's profile →
Citations per field
00.5×1.7×
Afsane Vaezi · 1×
Citations per year

Countries citing papers authored by Emily L. Larkin

Since Specialization
Citations

This map shows the geographic impact of Emily L. Larkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily L. Larkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily L. Larkin more than expected).

Fields of papers citing papers by Emily L. Larkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily L. Larkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily L. Larkin. The network helps show where Emily L. Larkin may publish in the future.

Co-authorship network of co-authors of Emily L. Larkin

This figure shows the co-authorship network connecting the top 25 collaborators of Emily L. Larkin. A scholar is included among the top collaborators of Emily L. Larkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily L. Larkin. Emily L. Larkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 23
2 42
3 79
4 64
5 118
6
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formationbreakdown →
316
7 23
8 153
9 64
10 5
11 14
12 18
13 3

About Emily L. Larkin

Emily L. Larkin is a scholar working on Infectious Diseases, Microbiology and Biotechnology, having authored 13 papers that have together received 922 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (6 papers) and Essential Oils and Antimicrobial Activity (2 papers). The work is most often cited by research in Infectious Diseases (785 citations), Epidemiology (611 citations) and Applied Microbiology and Biotechnology (35 citations). Emily L. Larkin has collaborated with scholars based in United States. Frequent co-authors include Mahmoud A. Ghannoum, Lisa Long, Christopher Hager, Katyna Borroto–Esoda, N. Isham, Steve Wring, Jennifer L. Cadnum, Curtis J. Donskey, Aaron Shaikh and Christina Piedrahita. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Journal of Adolescent Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026